-
Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)
Sep 9, 2025, 16:22 PM -
Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic
Sep 9, 2025, 16:22 PM -
Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Assessing the Use of Artificial Intelligence in Publication-Grade Research: A Literature Review of Applications in HEOR
Sep 9, 2025, 16:22 PM -
From GVD to HTA: Preparing for Success in the EU JCA Era With GenAI-Enhanced Efficiency
Sep 9, 2025, 16:22 PM -
From Unstructured Text to Enriched Data: Evaluating Large Language Models for Clinical Information Extraction From Echocardiogram Reports
Sep 9, 2025, 16:22 PM -
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
Surrogate Endpoints in German Health Technology Assessment: Post Hoc Analyses of the Phase III PROTECT Study Highlight the Efficacy of Sparsentan in Slowing Down the Loss of Kidney Function in IgAN Patients
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel vs. Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukemia
Sep 9, 2025, 16:22 PM -
From Diagnosis to Treatment: Evaluating Timeliness and Treatment Patterns in Czech Pancreatic Cancer Patients
Sep 9, 2025, 16:22 PM -
Clinical Outcomes In HTA Appraisal Reports Of Oncology Medicines In Portugal: A Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
How Cost-Effectiveness and Budget Impact Drive Pricing and Reimbursement: Insights From an International Comparative Study
Sep 9, 2025, 16:22 PM -
Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Nalbuphine Compared With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Pegunigalsidase Alfa Elfabrio® as a Long-Term Enzyme Replacement Therapy in Adults With Fabry Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Sep 9, 2025, 16:22 PM -
Early Access Programs and Pricing and Reimbursement Agreements of Orphan Medicines in Portugal
Sep 9, 2025, 16:22 PM -
Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK
Sep 9, 2025, 16:22 PM
